Treatment of Depression in Acute Coronary Syndromes with Selective Serotonin Reuptake Inhibitors

被引：0
|
作者：
Joost P. van Melle
Peter de Jonge
Maarten P. van den Berg
Harm J. Pot
Dirk J. van Veldhuisen
机构：
[1] University Medical Center Groningen,Department of Cardiology, Thoraxcenter
[2] University of Groningen,Department of Internal Medicine and Psychiatry
[3] University Medical Center Groningen,Department of Psychiatry
[4] University of Groningen,undefined
[5] University Medical Center Groningen,undefined
[6] University of Groningen,undefined
来源：
Drugs | 2006年 / 66卷
关键词：
Acute Coronary Syndrome; Heart Rate Variability; Fluoxetine; Paroxetine; Sertraline;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Depression in patients with acute coronary syndromes (ACS) is common and associated with impaired cardiovascular prognosis in terms of cardiac mortality and new cardiovascular events. It remains unclear whether antidepressant treatment may reverse these effects. In this review, the literature is evaluated on (i) the antidepressant efficacy of selective serotonin reuptake inhibitors (SSRIs) for depression in patients with ACS; (ii) the pleiomorphic effects of SSRIs that may be associated with cardiovascular prognosis; and (iii) the effects of SSRIs on cardiovascular prognosis.
引用
收藏
页码：2095 / 2107
页数：12
相关论文
共 50 条
  • [41] Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose
    Isbister, GK
    Bowe, SJ
    Dawson, A
    Whyte, IM
    JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY, 2004, 42 (03): : 277 - 285
  • [42] Systematic Review and Guide to Selection of Selective Serotonin Reuptake Inhibitors
    J. Guy Edwards
    Ian Anderson
    Drugs, 1999, 57 : 507 - 533
  • [43] HUSSERLIAN SELF-AWARENESS AND SELECTIVE SEROTONIN REUPTAKE INHIBITORS
    Hadreas, Peter
    PHILOSOPHY PSYCHIATRY & PSYCHOLOGY, 2010, 17 (01) : 43 - 51
  • [44] The Economics of Selective Serotonin Reuptake Inhibitors In DepressionA Critical Review
    Lori Frank
    Dennis A. Revicki
    Sonja V. Sorensen
    Ya-Chen Tina Shih
    CNS Drugs, 2001, 15 : 59 - 83
  • [45] Enantioselective LC analysis and determination of selective serotonin reuptake inhibitors
    Sethi, Sonika
    Bhushan, Ravi
    BIOMEDICAL CHROMATOGRAPHY, 2020, 34 (01)
  • [46] Drug Interactions of Clinical Significance with Selective Serotonin Reuptake Inhibitors
    Philip B. Mitchell
    Drug Safety, 1997, 17 : 390 - 406
  • [47] Effects of selective serotonin reuptake inhibitors on DNA damage in patients with depression
    Ahmadimanesh, Mahnaz
    Abbaszadegan, Mohammad Reza
    Morshedi Rad, Dorsa
    Moallem, Seyed Adel
    Mohammadpour, Amir Hooshang
    Ghahremani, Mohammad Hossein
    Farid Hosseini, Farhad
    Behdani, Fatemeh
    Akhondpour Manteghi, Ali
    Jowsey, Paul
    Shabani Behbahani, Fatemeh
    Moallem, Seyed Mohammad Hassan
    Etemad, Leila
    JOURNAL OF PSYCHOPHARMACOLOGY, 2019, 33 (11) : 1364 - 1376
  • [48] SELECTIVE SEROTONIN REUPTAKE INHIBITORS - EFFECTS OF CHRONIC TREATMENT ON ETHANOL-REINFORCED BEHAVIOR IN MICE
    GULLEY, JM
    MCNAMARA, C
    BARBERA, TJ
    RITZ, MC
    GEORGE, FR
    ALCOHOL, 1995, 12 (03) : 177 - 181
  • [49] Metabolic Abnormalities Related to Treatment With Selective Serotonin Reuptake Inhibitors in Patients With Schizophrenia or Bipolar Disorder
    Fjukstad, Katrine Kveli
    Engum, Anne
    Lydersen, Stian
    Dieset, Ingrid
    Steen, Nils Eiel
    Andreassen, Ole A.
    Spigset, Olav
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2016, 36 (06) : 615 - 620
  • [50] Switching Selective Serotonin Reuptake Inhibitors in Adolescents with Selective Serotonin Reuptake Inhibitor-Resistant Major Depressive Disorder: Balancing Tolerability and Efficacy
    Strawn, Jeffrey R.
    Mills, Jeffrey A.
    Croarkin, Paul E.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2019, 29 (04) : 250 - 255
12345